CXCL9 and inflammatory skin disease: Proinflammatory FB populations have been recently described in other inflammatory skin diseases, including Th2 responsive COL6A5+COL18A1+ FBs in atopic dermatitis and T cell–attracting CXCL9/CXCL10-expressing FBs in vitiligo (30, 31).